Stocktoria

Pharmagreen Biotech Inc. PHBI

Pharmagreen Biotech Inc. financials (annual, from 10-K)

Revenue
20182019202020212022
Net income
20182019202020212022
Free cash flow
20182019202020212022

Bars are annual figures from 2018 to 2022; red bars are negative (a loss or cash outflow).

MetricFY2022FY2021FY2020FY2019FY2018
R&D expense$3,956$7,619
Operating income-$1.1M-$744,064-$485,756-$642,178-$748,717
Interest expense$298,942$3,783
Income tax$0$0$0
Net income-$875,505-$4.5M-$2.5M-$767,537-$1.1M
Operating cash flow-$426,568-$206,081-$607,634-$317,832-$785,534
Free cash flow-$513,959-$1.0M
Cash & equivalents$25,300$12,196$62,682
Inventory$0
Total assets$208,971$373,081$266,245$630,272$449,420
Total liabilities$2.0M$2.1M$3.2M$1.5M$1.8M
Shareholders' equity-$1.8M-$1.7M-$2.9M-$834,498-$1.4M

Source: SEC EDGAR filings · CIK 0001435181 · US · as of 2022-09-30. facts plus Stocktoria's own computed scores — not investment advice.